Literature DB >> 2960400

Monoclonal antibody against a nuclear matrix antigen in proliferating human cells.

R N Philipova1, N Z Zhelev, I T Todorov, A A Hadjiolov.   

Abstract

A monoclonal antibody of the IgG2a subclass was isolated from the supernate of a hybridoma line obtained with splenocytes from a mouse immunized with a crude nucleolar fraction of human Namalwa cells. This antibody identifies a single nuclear polypeptide antigen characterized by: (a) presence in proliferating human cell lines and phytohemagglutinin-stimulated lymphocytes, but absence in resting lymphocytes; (b) appearance in stimulated lymphocytes in parallel with the onset of DNA synthesis; (c) a speckled distribution in the nucleoplasm; (d) tight association with nuclear matrix structures identified by both biochemical and in situ extraction and enzyme treatment procedures; (e) mol wt of 125 kDa and pI 6.5 as determined by immunoprecipitation or immunoblotting of nuclear or nuclear matrix proteins fractionated by gel electrophoresis. The above characteristics identify the p125/6.5 nuclear matrix protein recognized by the isolated monoclonal antibody as belonging to the class of proliferating cell nuclear antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960400     DOI: 10.1111/j.1768-322x.1987.tb00539.x

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  3 in total

1.  Nuclear matrins: identification of the major nuclear matrix proteins.

Authors:  H Nakayasu; R Berezney
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

2.  Asen Hadjiolov, remembered.

Authors:  K V Hadjiolova; J P Bachellerie; K Vaptzarova; G Markov; P Popov; K Markov; G Russev
Journal:  Chromosoma       Date:  1997-06       Impact factor: 4.316

3.  The effect of sodium tetrathionate stabilization on the distribution of three nuclear matrix proteins in human K562 erythroleukemia cells.

Authors:  L M Neri; B M Riederer; R A Marugg; S Capitani; A M Martelli
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.